Breaking News Instant updates and real-time market news.

CMI

Cummins

$139.70

(0.00%)

, BZUN

Baozun

$52.66

(0.00%)

09:40
08/14/18
08/14
09:40
08/14/18
09:40

Unusually active option classes on open August 14th

Unusual total active option classes on open include: Cummins (CMI), Baozun (BZUN), Tapestry (TPR), Home Depot (HD), Southwestern Energy (SWN), Newell Brands (NWL), Energy Sector SPDR ETF (XLE), FXI (FXI), Macy's (M), and Alibaba (BABA).

CMI

Cummins

$139.70

(0.00%)

BZUN

Baozun

$52.66

(0.00%)

TPR

Tapestry

$47.42

(0.00%)

HD

Home Depot

$194.11

(0.00%)

SWN

Southwestern Energy

$5.34

(0.00%)

NWL

Newell Brands

$20.47

(0.00%)

XLE

Energy Select Sector SPDR

$74.30

(0.00%)

FXI

iShares China Large-Cap ETF

$42.15

(0.00%)

M

Macy's

$40.08

(0.00%)

BABA

Alibaba

$177.65

(0.00%)

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 15

    Aug

  • 23

    Aug

  • 10

    Sep

  • 12

    Sep

  • 17

    Sep

CMI Cummins
$139.70

(0.00%)

08/01/18
WELS
08/01/18
NO CHANGE
Target $158
WELS
Market Perform
Cummins price target raised to $158 from $150 at Wells Fargo
Wells Fargo analyst Andrew Casey raised his price target for Cummins to $158 from $150 as its underlying operations are performing well against improving market conditions. However, the analyst says the company encountered another quarter of charges for legacy product issues that marred the performance. He reiterates a Market Perform rating on the shares.
07/23/18
OPCO
07/23/18
NO CHANGE
Target $168
OPCO
Outperform
Cummins price target lowered to $168 from $192 at Oppenheimer
Oppenheimer analyst Colin Rusch lowered his price target for Cummins to $168 from $192 on lower valuation multiple and modestly lower FY19 EBITDA. The analyst reiterates an Outperform rating on the shares.
07/10/18
07/10/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. CarMax (KMX) upgraded two notches to Overweight from Underweight at Morgan Stanley with analyst Armintas Sinkevicius saying longer term, he is constructive on dealers, citing a belief that tech disruption could accelerate consolidation and set up a transition toward "megafleet managers." 2. Cummins (CMI) upgraded to Buy from Hold at Stifel with analyst Michael Baudendistel saying shares of truck equipment companies have been under pressure primarily on concerns that the cycle is at a peak. 3. Wynn Resorts (WYNN) upgraded to Buy from Hold at Stifel with analyst Steven Wieczynski saying he believes the pullback in the stock recently has created a compelling opportunity. 4. KB Home (KBH) upgraded to Positive from Neutral at Susquehanna with analyst Jack Micenko citing a "clear and visible path" to further gross margin expansion and re-acceleration in community count and order growth well into 2019 for the upgrade, adding that underlying housing trends are strong in many of the markets in which the company currently operates despite "cautious" macro sentiment. 5. Quest Diagnostics (DGX) upgraded to Outperform from In Line at Evercore ISI with analyst Ross Muken saying the company will likely be the beneficiary of improved volumes, stable pricing, heightened M&A, and fund flows amid the heightened volatility within the Rx supply chain. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/10/18
07/10/18
UPGRADE
Target $160

Buy
Stifel upgrades Cummins to Buy on 'stronger for longer' view of truck equipment
As previously reported, Stifel analyst Michael Baudendistel upgraded Cummins to Buy from Hold, stating that shares of truck equipment companies have been under pressure primarily on concerns that the cycle is at a peak. However, Baudendistel holds a "stronger for longer" view on the truck equipment market, mainly due to robust freight rates, he tells investors. Additionly, Baudendistel highlights Cummins' potential to utilize its balance sheet to complete one or more transformative acquisitions. Given that the company's end markets are generally at higher than average points in their respective cycles, he lowered his price target on Cummins shares, however, to $160 from $174.
BZUN Baozun
$52.66

(0.00%)

03/06/18
LYON
03/06/18
DOWNGRADE
LYON
Outperform
Baozun downgraded earlier to Outperform from Buy at CLSA
08/31/17
SBSH
08/31/17
INITIATION
Target $38
SBSH
Buy
Baozun initiated with a Buy at Citi
Target $38.
08/23/17
08/23/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Ultragenyx (RARE) downgraded to Hold from Buy at SunTrust, with analyst Edward Nash slashing his price target to $55 from $105 after the company reported negative topline data from the Phase III trial for Ace-ER for GNE myopathy. Nash is disappointed by this first major clinical setback for the company and removed Ace-ER from his valuation models. 2. Duluth Holdings (DLTH) downgraded to Market Perform from Outperform at Raymond James, with analyst Dan Wewer citing increasing industry challenges. Wewer is concerned about increasing promotional activity and aggressive pricing tactics by competitors. 3. Cree (CREE) downgraded to Underweight from Equal Weight at Stephens. 4. Washington Prime (WPG) downgraded to Underperform from Neutral at Boenning & Scattergood by analyst Floris van Dijkum due to a more expensive NAV relative valuation caused by the more than 6% sector outperformance in the current quarter. 5. Baozun (BZUN) downgraded to Hold from Buy at Deutsche Bank by analyst Eileen Deng citing valuation after the stock's 18% rise in the past six months. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/23/17
DBAB
08/23/17
DOWNGRADE
Target $30
DBAB
Hold
Baozun downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Eileen Deng downgraded Baozun to Hold from Buy citing valuation after the stock's 18% rise in the past six months. Given the outsized advance, Deng feels the company's future catalysts are already reflected in its share price, she tells investors. However, she raised her price target on Baozun to $30 from $25.
TPR Tapestry
$47.42

(0.00%)

06/25/18
GSCO
06/25/18
INITIATION
GSCO
Sell
PVH Corp. initiated with a Sell at Goldman Sachs
Goldman Sachs analyst Alexandra Walvis initiated PVH Corp (PVH) with a Sell, telling investors in a research note that while the company has benefited from a strong acceleration in growth in Tommy Hilfiger and Calvin Klein, she believes momentum is peaking as a number of tailwinds fade. This morning, Walvis also initiated shares of Tapestry (TPR) with a Conviction Buy and Tiffany (TIF) and VFC (VFC) with a Buy.
06/25/18
GSCO
06/25/18
INITIATION
GSCO
Buy
VF Corp. initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Alexandra Walvis initiated VFC Corp (VFC) with a Buy rating, telling investors in a research note that VFC is an "under-appreciated growth asset," with brands with momentum like Vans and "credible" turnaround potential like Wrangler and The North Face, many of which have opportunities for channel shift enabled by digital. The analyst says she is "enthusiastic" about opportunities to deploy cash given VFC's strong balance sheet and expertise in integrating acquisitions. This morning, Walvis also initiated shares of Tapestry (TPR) with a Conviction Buy, Tiffany (TIF) with a Buy and PVH (PVH) with a Sell.
07/09/18
WELS
07/09/18
NO CHANGE
Target $56
WELS
Outperform
Tapestry fundamental story intact, guidance likely near-term issue, says Wells Fargo
Wells Fargo analyst Ike Boruchow remains bullish on the Tapestry story and reiterates the name as one of his top idea as he has gained greater confidence in both the Kate Spade turnaround efforts, as well as the trajectory of Coach brand. That said, the analyst does see some headwinds to next full year that the Street does not appear to be modeling, leading him to cut his FY19 EPS as he believes guidance is likely a near-term issue. Boruchow reiterates an Outperform rating and $56 price target on the shares.
07/31/18
UBSW
07/31/18
NO CHANGE
Target $59
UBSW
Buy
Tapestry price target lowered to $59 from $62 at UBS
UBS analyst Jay Sole said one of the main tenets of his buy thesis on Tapestry was that a product shift mix will lead to more full price selling. He recent research has led him to begin to doubt that will occur so he lowered his estimates and price target to reflect it. Sole said he still sees a favorable risk/reward for Tapestry and reiterated his Buy rating while lowering his target to $59 from $62.
HD Home Depot
$194.11

(0.00%)

08/14/18
GSCO
08/14/18
NO CHANGE
GSCO
Neutral
Home Depot 2H deceleration as expected, says Goldman Sachs
Goldman Sachs analyst Matthew Fassler said Neutral rated Home Depot reported a solid Q2 beat and guided to a 2H 2018 deceleration against tougher storm-driven comps. Fassler expects the stock to have an in-line reaction to the print and said the read through for Lowe's (LOW) suggests an in-line report with his forecast.
08/10/18
OPCO
08/10/18
NO CHANGE
Target $220
OPCO
Outperform
Home Depot price target raised to $220 from $205 at Oppenheimer
Oppenheimer analyst Brian Nagel raised his price target on Home Depot to $220 from $205 ahead of the company's Q2 earnings report, citing his continued confidence in the potential for Home Depot to capitalize on favorable demand dynamics in the home improvement space. In a research note to investors, Nagel said he remains bullish and looks towards the Q2 results as a potential near-term positive catalyst for shares. Nagel has an Outperform rating on Home Depot.
08/03/18
PIPR
08/03/18
DOWNGRADE
Target $39
PIPR
Neutral
Floor & Decor downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Peter Keith downgraded Floor & Decor (FND) to Neutral and lowered his price target for the shares to $39 from $58. The analyst, who admits his June upgrade of the stock was wrong, highlights Luxury Vinyl Tile's disruptive nature on the industry and Home Depot's (HD) "strong share gains" in flooring following Floor & Decor's Q2 miss and guide down. The quarter suggests the impact of these dynamics is occurring faster than anticipated, Keith tells investors in a research note. JPMorgan this morning also downgraded Floor & Decor.
07/27/18
BARD
07/27/18
NO CHANGE
BARD
GDP report included encouraging data for home improvement retailers, says Baird
Baird analyst Peter Benedict said that the Q2 GDP report included a few encouraging data points on housing that reinforced his positive near- and long-term view on Home Depot (HD) and Lowe's (LOW). Specifically, he points out that growth in private residential investment accelerated to 7.4%year-over-year. Benedict noted that changes in PRI and home center comps have a "strong historical correlation." He also noted that household formation accelerated to an annualized pace of 1.7M in Q2 from about a 1.2M rate in Q1. Benedict has Overweight ratings on both Home Depot and Lowe's.
SWN Southwestern Energy
$5.34

(0.00%)

04/17/18
SBSH
04/17/18
DOWNGRADE
Target $5
SBSH
Neutral
Southwestern Energy downgraded to Neutral from Buy at Citi
Citi analyst Robert Morris downgraded Southwestern Energy to Neutral and lowered his price target for the shares to $5 from $6. The analyst made a series of downgrades after lowering his 2018 composite spot natural gas price forecast to $2.75/MMBtu from $3.00/MMBtu, and for 2019 to $2.60/MMBtu from $3.35/MMBtu. He sees higher oil prices adversely impacting the outlook for U.S. natural gas prices.
05/22/18
STFL
05/22/18
INITIATION
Target $4.3
STFL
Hold
Southwestern Energy resumed with a Hold at Stifel
Stifel analyst Jane Trotsenko resumed Southwestern Energy with a Hold rating and a price target of $4.30, saying its upcoming years are as exciting as the developments made since 2014. The analyst points to the company's intention to divest its Fayetteville assets to become a "pure play exposure to the Appalachian basin", with lower debt levels, improved realization, and higher production rates. Trotsenko adds the acceleration of its liquids-rich West Virginia Marcellus assets also diversifies its income stream with higher exposure to liquids.
05/23/18
MSCO
05/23/18
UPGRADE
MSCO
Overweight
Whiting Petroleum, Oasis Petroleum upgraded to Overweight at Morgan Stanley
As previously reported, Morgan Stanley analyst Drew Venker upgraded both Whiting Petroleum (WLL) and Oasis Petroleum (OAS), each to Overweight from Equal Weight, citing stronger oil prices, improving capital discipline, and positive momentum in the Bakken play. He raised his price target on Whiting to $71 from $43 and increased his price target for Oasis to $19 from $11. Venker also increased his price targets on several other mid-cap E&Ps, including Antero Resources (AR), Continental Resources (CLR), Diamondback Energy (FANG), Energen (EGN), EQT (EQT), Gulfport (GROR), Parsley (PE), Range Resources (RRC) and Southwestern Energy (SWN).
06/22/18
RILY
06/22/18
NO CHANGE
Target $10
RILY
Buy
Southwestern Energy price target raised to $10 from $7.85 at B. Riley FBR
B. Riley FBR analyst Rehan Rashid raised his price target for Southwestern Energy to $10 and keeps a Buy rating on the shares.
NWL Newell Brands
$20.47

(0.00%)

04/17/18
04/17/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Hold from Sell at Pivotal Research with analyst Brian Wieser saying the company "has a lot of positive elements" heading into the back half of the year, including a strong film slate, the launch of new direct to consumer over-the-top services, and efforts in support of the close of the Fox (FOXA) transaction. 2. Coca-Cola (KO) upgraded to Neutral from Sell at Goldman Sachs with analyst Judy Hong saying she sees an improving organic sales growth outlook, "cleaner base" post-refranchising, and better visibility on its margin and earnings targets. 3. Merck (MRK) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst David Risinger saying the Keytruda+chemo combination showed better than expected results in lung cancer, boosting the company's immuno-oncology lead against Bristol-Myers (BMY). 4. Newell Brands (NWL) upgraded to Outperform from Market Perform at Wells Fargo with analyst Bonnie Herzog saying the stock's setup is good looking forward, with greater potential upside than downside risk over the next 12 months. 5. Twitter (TWTR) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Brian Nowak citing recent advertiser conversations that have continued to be incrementally positive about Twitter's ad business. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/07/18
DBAB
08/07/18
NO CHANGE
Target $23
DBAB
Hold
Newell Brands price target lowered to $23 from $29 at Deutsche Bank
Deutsche Bank analyst Steve Powers lowered his price target for Newell Brands to $23 and keeps a Hold rating on the shares. The analyst views yesterday's 14% selloff post-earnings selloff as warranted. Newell's confidence around its ability to offset the negative impact of tariffs via pricing seems "somewhat uncertain," Powers tells investors in a research note.
08/09/18
SBSH
08/09/18
NO CHANGE
SBSH
Buy
Newell Brands selloff this week bit of an overreaction, says Citi
Citi analyst Wendy Nicholson believes the 22% selloff in shares of Newell Brands since Monday's Q2 results "seems like a bit of an overreaction." The quarter largely came in as expected, though a lower tax rate and share count offset weaker profit margins, Nicholson tells investors in a research note. She says what matters most right now is Newell's asset sales. The analyst keeps a Buy rating on the shares.
04/17/18
WELS
04/17/18
UPGRADE
Target $33
WELS
Outperform
Newell Brands upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Bonnie Herzog upgraded Newell Brands to Outperform and raised her price target for the shares to $33 from $25. The stock's setup is good looking forward, with greater potential upside than downside risk over the next 12 months, Herzog tells investors in a research note. She calls her upgrade more of an event-driven break-up call versus a fundamental improvement call. The analyst's break-up analysis suggests the targeted $10B after-tax proceeds from the planned divestitures could prove conservative. Newell's current valuation is not reflective of its underlying value, Herzog contends.
XLE Energy Select Sector SPDR
$74.30

(0.00%)

10/03/17
MSCO
10/03/17
NO CHANGE
MSCO
Energy sector upgraded to 'Attractive' at Morgan Stanley
Morgan Stanley analysts led by Martijn Rats upgraded the Energy sector to "Attractive," saying they see increasingly clear signs that oil prices and production costs are near to finding a new equilibrium and that the sector's 6-year bear market is set to come to an end. Oil demand continues to grow well above historical trend rates and the downstream outlook is "outright strong," the team tells investors. In developed markets, the best positioned to benefit are downstream focused firms and high yielding majors, such as Shell (RDS.A), BP (BP) and Repsol (REPYY), the analysts said.
FXI iShares China Large-Cap ETF
$42.15

(0.00%)

M Macy's
$40.08

(0.00%)

08/10/18
STPT
08/10/18
DOWNGRADE
STPT
Hold
Macy's downgraded to Hold from Buy at Standpoint Research
06/27/18
CLVD
06/27/18
NO CHANGE
CLVD
Neutral
Macy's assume with a Neutral at Cleveland Research
Cleveland Research analyst Rusty WIlson assumed coverage on Macy's with a Neutral syaing the near-term outlook appears positive, offset by continued structural concerns medium/longer-term.
06/21/18
UBSW
06/21/18
INITIATION
Target $39
UBSW
Neutral
Macy's initiated with a Neutral at UBS
UBS analyst Jay Sole started Macy's with a Neutral rating and $39 price target.
06/06/18
06/06/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Yelp (YELP) downgraded to Sector Weight from Overweight at KeyBanc analyst Brad Erickson saying his latest customer checks, combined with updated views of Request a Quote, diminish his prior views for upside potential in the name. 2. Macy's (M) downgraded to Neutral from Overweight at Atlantic Equities while Kohl's (KSS) was downgraded to Underweight from Neutral. 3. BHP Billiton (BHP) and BHP Billiton plc (BBL) were downgraded to Neutral from Buy at BofA/Merrill. 4. Trimble (TRMB) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Jerry Revich saying while he is still bullish on the long-term outlook for rising adoption rates of Trimble's core productivity-enhancing software and hardware, he views the company's key end-markets as more balanced now. 5. Ambarella (AMBA) downgraded to Perform from Outperform at Oppenheimer with analyst Andrew Uerkwitz citing the company's Q1 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
BABA Alibaba
$177.65

(0.00%)

08/14/18
MKMP
08/14/18
NO CHANGE
Target $51
MKMP
Buy
JD.com has 'improving event path' and 'low valuation', says MKM Partners
MKM Partners analyst Rob Sanderson kept his Buy rating and $51 price target on JD.com (JD) ahead of its Q2 earnings this week, saying that while consensus expectations suggest concern with whether net margins can achieve the 0.9%, more bullish investors can be rewarded beyond this quarter. The analyst further notes that the loss of market share to Alibaba (BABA), along with China macro trade concerns, have weighed on the stock, but its "all-time low" valuation is compelling, and even a partial recovery in performance could yield a sizable move in the stock price.
08/09/18
STFL
08/09/18
DOWNGRADE
Target $2150
STFL
Hold
Booking Holdings downgraded to Hold on slowing growth at Stifel
As previously reported, Stifel analyst Scott Devitt downgraded Booking Holdings (BKNG) to Hold from Buy, citing the slowing growth at the company-formerly-known-as Priceline. Devitt lowered his core bookings growth expectations in 2018 and beyond following the company's Q2 earnings report and cut his price target on Booking shares to $2,150 from $2,332. He sees better large cap opportunities at company's with similar earnings multiples and better growth, such as Alibaba (BABA), Alphabet (GOOGL) and Facebook (FB), Devitt added.
07/09/18
DADA
07/09/18
NO CHANGE
Target $8
DADA
Buy
Groupon offers 'tremendous value' in potential sale, says DA Davidson
DA Davidson analyst Tom Forte kept his Buy rating and $8 price target on Groupon following speculation by Recode over the weekend that the company is looking to sell itself. Forte recommends that investors purchase shares, stating that the market is underpricing Groupon as its "North American business has never been in better shape and its international operations are well positioned". In a bull case, the analyst contends that Groupon could be worth $12 per share if it can improve its growth rate or find a strategic buyer where a deal would value the two companies higher than the sum of their parts. Forte speculates about Priceline (PCLN), Alibaba (BABA), Google (GOOGL), and Facebook (FB) as potential acquirers for Groupon.
07/06/18
RHCO
07/06/18
NO CHANGE
Target $215
RHCO
Buy
Alibaba price target lowered to $215 from $235 at SunTrust
SunTrust analyst Youssel Squali lowered his price target on Alibaba to $215, citing the impact of later than expected closing for Ele.me, whose $9.5B acquisition was announced in early April. The analyst is also tempering his expectations for growth in the Cloud segment while noting the adverse impact of the recent USD strength relative to the Renminbi. Longer term, Squali keeps his Buy rating on Alibaba, pointing to "exciting initiatives" around Ant Financial's new funding at $150B, exclusive online broadcasting rights of the World Cup, and promising initiatives around enterprise and voice.

TODAY'S FREE FLY STORIES

FII

Federated Investors

$24.65

-0.02 (-0.08%)

21:40
12/16/18
12/16
21:40
12/16/18
21:40
Initiation
Federated Investors initiated  »

Federated Investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIII

G-III Apparel

$28.68

-0.29 (-1.00%)

21:37
12/16/18
12/16
21:37
12/16/18
21:37
Upgrade
G-III Apparel rating change  »

G-III Apparel upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLXT

Calyxt

$9.88

0.4 (4.22%)

21:34
12/16/18
12/16
21:34
12/16/18
21:34
Upgrade
Calyxt rating change  »

Goldman upgrades Calyxt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLXT

Calyxt

$9.88

0.4 (4.22%)

20:23
12/16/18
12/16
20:23
12/16/18
20:23
Upgrade
Calyxt rating change  »

Calyxt upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEQP

Crestwood Equity

$32.29

0.47 (1.48%)

, EQM

EQT Midstream Partners

$46.86

-0.1 (-0.21%)

20:08
12/16/18
12/16
20:08
12/16/18
20:08
Recommendations
Crestwood Equity, EQT Midstream Partners analyst commentary at Goldman Sachs »

Goldman upgrades…

CEQP

Crestwood Equity

$32.29

0.47 (1.48%)

EQM

EQT Midstream Partners

$46.86

-0.1 (-0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITW

Illinois Tool Works

$131.02

-2.26 (-1.70%)

19:57
12/16/18
12/16
19:57
12/16/18
19:57
Downgrade
Illinois Tool Works rating change at Deutsche Bank »

Illinois Tool Works…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWK

Stanley Black & Decker

$118.36

0.46 (0.39%)

19:57
12/16/18
12/16
19:57
12/16/18
19:57
Upgrade
Stanley Black & Decker rating change at Deutsche Bank »

Stanley Black &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$66.24

-1.04 (-1.55%)

, AET

Aetna

$0.00

(0.00%)

19:31
12/16/18
12/16
19:31
12/16/18
19:31
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

INCY

Incyte

$66.24

-1.04 (-1.55%)

AET

Aetna

$0.00

(0.00%)

ANTM

Anthem

$275.59

-4.93 (-1.76%)

CNC

Centene

$127.55

-5.3 (-3.99%)

CI

Cigna

$205.34

-6.63 (-3.13%)

HNT

Health Net

$0.00

(0.00%)

HUM

Humana

$300.41

-12.09 (-3.87%)

MOH

Molina Healthcare

$131.72

-11.19 (-7.83%)

UNH

UnitedHealth

$265.06

-7.2 (-2.64%)

WCG

WellCare

$236.90

-7.44 (-3.04%)

SNE

Sony

$51.32

-0.88 (-1.69%)

GOOG

Alphabet

$1,041.68

-21.44 (-2.02%)

GOOGL

Alphabet Class A

$1,050.62

-23.36 (-2.18%)

AAPL

Apple

$165.48

-5.45 (-3.19%)

BAC

Bank of America

$24.49

0.1 (0.41%)

BLK

BlackRock

$382.25

-5.29 (-1.37%)

CAT

Caterpillar

$126.78

0.79 (0.63%)

CVX

Chevron

$113.84

-2.15 (-1.85%)

DDAIF

Daimler AG

$0.00

(0.00%)

DAL

Delta Air Lines

$53.50

-0.03 (-0.06%)

ET

Energy Transfer LP

$14.08

-0.5 (-3.43%)

TOL

Toll Brothers

$32.23

-0.4 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 10

    Jan

  • 29

    Jan

  • 05

    Feb

  • 12

    Feb

  • 19

    Feb

  • 24

    Feb

  • 03

    Mar

EQT

EQT Corporation

$19.40

-0.78 (-3.87%)

18:54
12/16/18
12/16
18:54
12/16/18
18:54
Periodicals
EQT's board to seek meeting with Rice brothers, Reuters reports »

EQT Corporation's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQM

EQT Midstream Partners

$46.86

-0.1 (-0.21%)

, EQGP

EQGP Holdings

$19.94

0.02 (0.10%)

18:31
12/16/18
12/16
18:31
12/16/18
18:31
Downgrade
EQT Midstream Partners, EQGP Holdings rating change at Goldman Sachs »

EQT Midstream downgraded…

EQM

EQT Midstream Partners

$46.86

-0.1 (-0.21%)

EQGP

EQGP Holdings

$19.94

0.02 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEQP

Crestwood Equity

$32.29

0.47 (1.48%)

18:28
12/16/18
12/16
18:28
12/16/18
18:28
Upgrade
Crestwood Equity rating change at Goldman Sachs »

Crestwood Equity upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$66.24

-1.04 (-1.55%)

17:52
12/16/18
12/16
17:52
12/16/18
17:52
Hot Stocks
Innovent, Incyte announce agreement for three clinical-stage candidates in China »

Incyte and Innovent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

NSANY

Nissan

$0.00

(0.00%)

, RNLSY

Renault

$0.00

(0.00%)

17:14
12/16/18
12/16
17:14
12/16/18
17:14
Periodicals
Renault seeking Nissan shareholder meeting amid Ghosn crisis, Reuters says »

Renault (RNLSY) requested…

NSANY

Nissan

$0.00

(0.00%)

RNLSY

Renault

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

T

AT&T

$30.24

0.33 (1.10%)

, CMCSA

Comcast

$36.32

-0.43 (-1.17%)

16:48
12/16/18
12/16
16:48
12/16/18
16:48
Hot Stocks
Box Office Battle: 'Spider-Verse' wins weekend with $35M »

Sony's (SNE)…

T

AT&T

$30.24

0.33 (1.10%)

CMCSA

Comcast

$36.32

-0.43 (-1.17%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$51.32

-0.88 (-1.69%)

FOX

21st Century Fox

$48.79

-0.09 (-0.18%)

FOXA

21st Century Fox

$49.06

-0.07 (-0.14%)

LGF.A

Lionsgate

$15.59

-0.16 (-1.02%)

DIS

Disney

$112.21

-1.17 (-1.03%)

VIAB

Viacom

$28.56

-0.31 (-1.07%)

VIA

Viacom

$31.23

-0.4 (-1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 30

    Jan

  • 20

    Mar

ELGX

Endologix

$0.71

0.0232 (3.39%)

16:17
12/16/18
12/16
16:17
12/16/18
16:17
Conference/Events
Endologix to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRPO

Precipio

$0.19

-0.0111 (-5.63%)

16:11
12/16/18
12/16
16:11
12/16/18
16:11
Conference/Events
Precipio to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSB

Mesabi Trust

$25.15

-1.1 (-4.19%)

16:08
12/16/18
12/16
16:08
12/16/18
16:08
Conference/Events
Mesabi Trust to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLNT

Melinta Therapeutics

$1.19

-0.1 (-7.75%)

16:02
12/16/18
12/16
16:02
12/16/18
16:02
Conference/Events
Melinta Therapeutics to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$75.63

-1.32 (-1.72%)

15:55
12/16/18
12/16
15:55
12/16/18
15:55
Periodicals
Exxon Mobil shareholders call for greenhouse gas reduction targets, Reuters says »

A number of institutional…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANTM

Anthem

$275.59

-4.93 (-1.76%)

, CNC

Centene

$127.55

-5.3 (-3.99%)

13:16
12/16/18
12/16
13:16
12/16/18
13:16
Periodicals
Health stocks preparing for market jolt after Obamacare ruling, Bloomberg says »

U.S. health-care stocks…

ANTM

Anthem

$275.59

-4.93 (-1.76%)

CNC

Centene

$127.55

-5.3 (-3.99%)

CI

Cigna

$205.34

-6.63 (-3.13%)

UNH

UnitedHealth

$265.06

-7.2 (-2.64%)

HUM

Humana

$300.41

-12.09 (-3.87%)

WCG

WellCare

$236.90

-7.44 (-3.04%)

MOH

Molina Healthcare

$131.72

-11.19 (-7.83%)

HNT

Health Net

$0.00

(0.00%)

AET

Aetna

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 05

    Feb

  • 19

    Feb

JELD

Jeld-Wen

$14.27

-0.46 (-3.12%)

13:02
12/16/18
12/16
13:02
12/16/18
13:02
Hot Stocks
Jeld-Wen announces final ruling in Steves & Sons litigation, to appeal decision »

Jeld-Wen announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRA

Atara Biotherapeutics

$41.78

-0.74 (-1.74%)

12:55
12/16/18
12/16
12:55
12/16/18
12:55
Hot Stocks
Atara Biotherapeutics presents positive efficacy, safety results for EBV + LMS »

Atara Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$133.95

2.595 (1.98%)

12:41
12/16/18
12/16
12:41
12/16/18
12:41
Hot Stocks
BeiGene announces updated Phase 1A/1B data on tislelizumab »

BeiGene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JELD

Jeld-Wen

$14.27

-0.46 (-3.12%)

12:35
12/16/18
12/16
12:35
12/16/18
12:35
Hot Stocks
Jeld-Wen ordered to divest Pennsylvania plant to restore competition »

Federal Judge Robert…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$52.11

-1.54 (-2.87%)

, RHHBY

Roche

$0.00

(0.00%)

04:55
12/16/18
12/16
04:55
12/16/18
04:55
Conference/Events
European Society for Medical Oncology (ESMO) to hold a conference »

ESMO Immuno-Oncology…

BMY

Bristol-Myers

$52.11

-1.54 (-2.87%)

RHHBY

Roche

$0.00

(0.00%)

CELG

Celgene

$68.20

-1.55 (-2.22%)

MRK

Merck

$76.50

-1.94 (-2.47%)

PFE

Pfizer

$43.84

-0.71 (-1.59%)

FLDM

Fluidigm

$7.79

-0.39 (-4.77%)

NEO

NeoGenomics

$13.25

-0.18 (-1.34%)

SGEN

Seattle Genetics

$60.46

-0.5 (-0.82%)

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

IMV

IMV Inc

$5.65

-0.14 (-2.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 24

    Dec

  • 29

    Dec

  • 11

    Jan

  • 11

    Jan

  • 24

    Jan

  • 16

    Feb

  • 18

    Mar

  • 20

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.